Although MEN1 mutation has been associated with recurrence and progression from grade II to III ependymoma (Urioste et al. 2002; Funayama et al. 2013), we offer the first clear evidence that MEN1 mutation is a driver of the founding clone. Here, MEN1 is linked to ependymoma.